Skip to content

Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)

Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07288021
Acronym
TOLERANCE
Enrollment
200
Registered
2025-12-17
Start date
2024-02-05
Completion date
2026-07-01
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor, Induced

Keywords

induction, balloon catheter, EMLA, Lidocaine/prilocaine, pain

Brief summary

The goal of this RCT is to learn if application of topical anesthetic cream to the perineum and posterior wall of vagina prior to balloon catheter insertion as part of labor induction will reduce pain levels experienced by pregnant individuals. All participants are 18 or older, carrying a singleton in vertex position and in need of labor induction, are late-preterm or term (34 weeks gestation and onward) and without contraindication to vaginal delivery. Investigators seek to compare pain levels and patient satisfaction between two groups: Nulliparous patients, using EMLA or placebo (randomized, double blinded). Multiparous patients, EMLA or placebo.

Interventions

DRUGTopical Analgesia with Lidocaine-Prilocaine cream

patients allocated to 'EMLA' arm will receive topical analgesia cream prior to speculum insertion, as part of the administration of balloon catheter insertion process. 3 puffs of the cream will be applied to the perineum, posterior fourchette and posterior vaginal wall by administrating physician. A pause of 7 minutes in the process will be made to allow for maximal analgesic affect.

OTHERPlacebo

patients allocated to 'Placebo' arm will receive lubrication with placebo cream prior to speculum insertion, as part of the administration of balloon catheter insertion process. 3 puffs of the cream will be applied to the perineum, posterior fourchette and posterior vaginal wall by administrating physician. A pause of 7 minutes in the process will be made.

Sponsors

Bnai Zion Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

Both creams (EMLA and placebo) are specially made in similar containers, labeled as A and B. Head of pharmacy in the study's medical center alone is aware which is EMLA or placebo. Both substances are of similar smell, texture and color.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women scheduled for labor induction with balloon catheter. * 18 years of age or older. * Singleton pregnancy with a cephalic presentation. * ≥ 34 completed gestational weeks. * Does not participate in any other trial that might affect maternal or fetal/neonatal outcomes. * No contraindication for vaginal delivery

Exclusion criteria

* Unable or unwilling to provide and sign informed consent forms. * Known sensitivity to EMLA or placebo substance. * Known vulvodynia or vaginismus - rendering vaginal examination not possible. * Any chronic pain syndrome

Design outcomes

Primary

MeasureTime frameDescription
Pain levels during insertiondirectly after application and insertion of balloon catheter.Pain levels during insertion of balloon catheter, as experienced by participant and ranked from 1 to 5 \[1 - no pain at all 2 - mild discomfort 3 -strong pain yet bearable 4 -severe pain 5 - unbearable pain (requires cessation of insertion)\].

Secondary

MeasureTime frameDescription
analgesia while with balloon catheter6-12 hoursneed for medical analgetics while with balloon catheter, to be checked by analgetics given by nursing staff while the patient is with the balloon cathether in place - a dichotomic variable (yes/no).
pain score during removal of catheterto be asked directly after removal, on a scale of 1-5.Pain levels during removal of balloon catheter, as experienced by participant and ranked from 1 to 5 \[1 - no pain at all 2 - mild discomfort 3 -strong pain yet bearable 4 -severe pain 5 - unbearable pain (requires cessation of insertion)\].
willingness to undergo cervical ripening with balloon catheter in the futureto be asked directly after removal, on a scale of 1-5.willingness to undergo cervical ripening with balloon catheter in the future, on a scale of 1-5 (1- no, not under any circumstances; 2 - only if no other option exists; 3 - ambivalent; 4 - yes, but with concern; 5 - yes, no problem).
analgesia during deliveryFrom time of balloon insertion until the time of delivery, assessed up to 3 days and to be checked immediately after delivery.need and use for medical analgetics during the delivery process, including epidural, dolestion and NO.
mode of deliveryat deliverymode of delivery - vaginal, operative vaginal of cesarean delivery
neonatal weightimmediately after deliveryneonatal weight in grams and percentile according to birth weight curves
cord blood gasup to 10 minutes after deliverycord blood gas levels, the first measurement taken after birth and up to 10 minutes after delivery.
Neonatal Intensive Care Unit (NICU) admissionfrom delivery and up to 1 weekNICU admission of newborn within first week of life
neonatal infection1st week after deliveryneonatal infection or suspicion of during birth hospitalization
duration of insertion procedureballoon insertion duration, estimated as up to 20 minutesduration of insertion of catheter procedure
difficulty of insertionto be reported by inserting doctor immediately after insertion procedure is completed, estimated up to 20 minutes.difficulty of insertion of catheter, as described by inserting physician
obstetric traumaup to an hour after deliverypresence of, and degree, of perineal lacerations
APGAR [Appearance (color), Pulse (heart rate), Grimace (reflex irritability), Activity (muscle tone), and Respiration (breathing)] scoreup to 10 minutes after deliveryAPGAR scores at 1, 5 and 10 minutes of life of newborn, as given by midwife/doctor present at the time. higher values on this score reflect a better outcome.

Other

MeasureTime frameDescription
Participant Satisfaction After Balloon Catheter Insertionthe patient is to be asked by inserting physician directly after insertion, on a scale of 1-5.satisfaction of participant from insertion of balloon catheter, as ranked by participant on a scale of 1-5 (1 - completely unhappy; 2 - slightly unhappy; 3 - ambivalent; 4 - mildly pleased; 5 - very pleased).

Countries

Israel

Contacts

Primary ContactDafna Ben Yehuda Raz, MD, resident doctor
dafna.ben-yehuda@b-zion.org.il+97248359366
Backup ContactInna Bleicher, MD, MFM specialist
inna.bleicher@b-zion.org.il+97248359366

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026